Copyright
©The Author(s) 2021.
World J Diabetes. Sep 15, 2021; 12(9): 1426-1441
Published online Sep 15, 2021. doi: 10.4239/wjd.v12.i9.1426
Published online Sep 15, 2021. doi: 10.4239/wjd.v12.i9.1426
Table 1 List of the keywords used for literature search
No. | |
1 | Dipeptidyl peptidase 4 inhibitor |
2 | DPP-4 inhibitor |
3 | Gliptins |
4 | ‘Autoimmune disease’ |
5 | [1] and [4] |
6 | [2] and [4] |
7 | [3] and [4] |
8 | [2] and [3] and [4] |
9 | Inflammatory bowel disease |
10 | [1] and [9] |
11 | Arthritis |
12 | Arthralgia |
13 | ‘Rheumatoid arthritis’ |
14 | [1] and [11] |
15 | [1] and [12] |
16 | [1] and [13] |
- Citation: Roy A, Sahoo J, Narayanan N, Merugu C, Kamalanathan S, Naik D. Dipeptidyl peptidase-4 inhibitor-induced autoimmune diseases: Current evidence. World J Diabetes 2021; 12(9): 1426-1441
- URL: https://www.wjgnet.com/1948-9358/full/v12/i9/1426.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i9.1426